Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2006-01-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.2005.068619PMID 16421119PMCID PMC2077579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased ability of peripheral blood lymphocytes to degrade laminin in multiple sclerosis.

  2004cited by this paper
• Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis.

  2002cited by this paper
• The Up-regulation of Stromelysin-1 (MMP-3) in a Spontaneously Demyelinating Transgenic Mouse Precedes Onset of Disease*

  2002cited by this paper
• Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.

  2001cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis.

  2000cited by this paper
• Multiple sclerosis: Pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-β

  2000cited by this paper
• Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.

  2000cited by this paper
• Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis.

  2000cited by this paper
• Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis.

  1999cited by this paper
• Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

  1999cited by this paper
• Metalloproteinases and their tissue inhibitors in multiple sclerosis.

  1999cited by this paper
• Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

  1998cited by this paper
• Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke

  1997cited by this paper
• Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions

  1997cited by this paper
• Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.

  1997cited by this paper
• The Expression of Tissue‐type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis: Comparison of Stages in Lesion Evolution

  1996cited by this paper
• Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis Lesions

  1996cited by this paper
• Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis

  1996cited by this paper
• A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies.

  1994cited by this paper
• The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion

  1994cited by this paper
• Matrix metalloproteinases: a review.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies.

  1993cited by this paper
• Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.

  1992cited by this paper
• Adhesion molecules and malignant gliomas: implications for tumorigenesis.

  1992cited by this paper
• The pathological evolution of multiple sclerosis

  1992cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies.

  1992cited by this paper
• Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.

  1991cited by this paper
• Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

  1991cited by this paper
• Adhesion-related molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis.

  1991cited by this paper
• Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.

  1987cited by this paper

• Oxidative Stress Markers in Multiple Sclerosis

  2024cites this paper
• The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?

  2023cites this paper
• Contribution of LTi and TH17 cells to B cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis

  2019cites this paper
• Plasma proteome in multiple sclerosis disease progression

  2019influential citation
• The emerging role of serum zinc in motor disability and radiological findings in patients with multiple sclerosis

  2019cites this paper
• Lower Serum Zinc Levels in Patients with Multiple Sclerosis Compared to Healthy Controls

  2018cites this paper
• 4 The Blood-Brain Barrier in Brain Tumours

  2017cites this paper
• Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation

  2017cites this paper
• Albumin and multiple sclerosis

  2016cites this paper
• Zinc in Multiple Sclerosis

  2016cites this paper
• Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers

  2016cites this paper
• The Role of Matrix Metalloproteinase 3 and 9 in the Pathogenesis of Acute Neuroinflammation. Implications for Disease Modifying Therapy

  2015cites this paper
• Functional promoter polymorphism of matrix metalloproteinase ( MMP )-3 5 A / 6 A and its interaction with MMP-7 A-181 G polymorphism in multiple sclerosis

  2015influential citation
• Extracellular Regulation of Glial Cell Functions

  2015cites this paper
• TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis

  2015cites this paper
• Serum MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in multiple sclerosisclinical subtypes and their diagnostic value in the progressive disease course.

  2014cites this paper
• Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?

  2014cites this paper
• Unmyelinated and Myelinated Axons Exhibit Differential Injury and Treatment Responses Following Traumatic Injury

  2014cites this paper
• The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.

  2014cites this paper
• Опыт применения препарата интерферона -1а в лечении рассеянного склероза у детей Оригинальная статья

  2013cites this paper
• Aqueous zymography screening of matrix metalloproteinase activity and inhibition based on colorimetric gold nanoparticles.

  2012cites this paper
• Decreased serum levels of nucleolin protein fragment, as analyzed by bead-based proteomic technology, in multiple sclerosis patients compared to controls.

  2012cites this paper
• Serum Levels of Matrix Metalloproteinases: Implications in Clinical Neurology

  2012cites this paper
• The disturbed blood-brain barrier in human glioblastoma.

  2012cites this paper
• Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis

  2012cites this paper
• Structure and functions of aquaporin-4-based orthogonal arrays of particles.

  2011cites this paper
• Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls

  2011cites this paper
• The Blood-Brain Barrier in Brain Tumours

  2011cites this paper
• Glial Cells in Brain Defense Mechanisms

  2010cites this paper
• Matrix metalloproteinases during and outside of migraine attacks without aura

  2010cites this paper
• Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: proteomic analysis.

  2010cites this paper
• Testing of the OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage in Rheumatoid Arthritis: A Systematic Literature Search on 5 Candidate Biomarkers

  2009cites this paper
• Agrin, Aquaporin-4, and Astrocyte Polarity as an Important Feature of the Blood-Brain Barrier

  2009cites this paper
• Cleavage of myelin associated glycoprotein by matrix metalloproteinases.

  2008cites this paper
• Brain endothelial cells and the glio-vascular complex

  2008cites this paper
• Endothelins stimulate the production of stromelysin-1 in cultured rat astrocytes.

  2008cites this paper
• Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia.

  2008cites this paper
• Differential Expression of Extracellular Matrix and Adhesion Molecule Genes in the Brain of Juvenile versus Adult Mice in Responses to Intracerebroventricular Administration of IL-1

  2007cites this paper
• SELÇUK ÜN‹VERS‹TES‹ TIP DERG‹S‹

  2007cites this paper
• The `never-ending story' of the influence of blood specimen collection methods affecting the concentration, the zymographic profile and the usefulness of matrix metalloproteinases and their tissue inhibitors in multiple sclerosis diagnosis/prognosis: a landmark for limiting the misuse of serum sampl

  2007cites this paper
• Astrocytes—Friends or foes in multiple sclerosis?

  2007cites this paper
• Neuronal 'On' and 'Off' signals control microglia.

  2007cites this paper
• Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators.

  2007cites this paper
• Highly Predictive CoMFA and CoMSIA Models for Two Series of Stromelysin-1 (MMP-3) Inhibitors Elucidate S1' and S1-S2' Binding Modes

  2006cites this paper
• A Preliminary in Silico Lead Series of 2-Phthalimidinoglutaric Acid Analogues Designed as MMP-3 Inhibitors

  2006cites this paper
• Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens

  2006cites this paper
• in Multiple Sclerosis Therapy b Skewing and the Efficacy of IFN-Elevation of Sema4A Implicates Th Cell

  year unknowncites this paper